HG
Therapeutic Areas
Mogling Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cdc42 Inhibition Platform (CASIN) | Multiple age-related diseases (e.g., Osteoporosis, Immunosenescence, Neurodegeneration) | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| Cdc42 Inhibition Platform (CASIN) | Multiple age-related diseases (e.g., Osteoporosis, Immunosenescence, Neurodegeneration) | Pre-clinical |